Foresight Diagnostics
Latest round
- Series B
Last raised
- Jul 2024
Total raised
- $86M
Investors
- 8
About Foresight Diagnostics
Foresight Diagnostics Inc.Founded in 2020 in Boulder, US, Foresight Diagnostics Inc. specializes in diagnostic solutions for oncology.Foresight Diagnostics specializes in advanced diagnostic solutions focused on cancer detection, particularly through their flagship offering, Foresight CLARITY™. This ultra-sensitive minimal residual disease (MRD) platform employs proprietary PhasED-Seq™ technology to identify and monitor circulating tumor DNA (ctDNA) across various cancer types, delivering actionable insights at critical stages of patient treatment. The company's testing services cater to both biopharma and academic researchers, facilitating the development and execution of clinical trials and exploratory research in oncology.Foresight Diagnostics generates revenue through partnerships and collaborations with biopharma companies and academic institutions, focusing on services related to their Foresight CLARITY™ platform. Transactions typically involve business-to-business arrangements, where clients engage Foresight for custom testing, regulatory support, and access to their advanced diagnostic technologies. The company provides both lab-developed tests and personalized assays, with details on specific pricing structures tailored to each partnership. Foresight's revenue stream is reinforced by its regulatory expertise, facilitating the development of companion diagnostics and integrating MRD testing as endpoints in clinical trials, ensuring that clients benefit from both the technical capabilities and regulatory support in their research endeavors. In December 2025, Natera, Inc. a portfolio company of Lightspeed Venture Partners, OrbiMed Advisors, Sofinnova Investments, Founders Fund, Claremont Creek Ventures, Alafi Capital, HealthCor Group, Harmony Partners, Franklin Templeton, RA Capital Management, and Transformation Capital acquired Foresight Diagnostics Inc. from Pear VC, Civilization Ventures, CU Healthcare Innovation Fund, Stanford University, BlueBird Ventures, Foresight Capital, Sadik Ventures, and Agent Capital for an upfront payment of USD 275 million and will receive additional payment of USD 175 million in all stock transaction upon achieving milestones.
Who invested in Foresight Diagnostics
8 investors across 4 rounds
See all investors in Foresight Diagnostics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Foresight Diagnostics
Who invested in Foresight Diagnostics?
Foresight Diagnostics has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Foresight Diagnostics raised?
Foresight Diagnostics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Foresight Diagnostics last raise money?
Foresight Diagnostics's most recent round on record is a Series B, in Jul 2024.
What does Foresight Diagnostics do?
Foresight Diagnostics is a biotechnology company.
Where is Foresight Diagnostics headquartered?
Foresight Diagnostics is headquartered in Boulder, US.
Which VCs invest in companies like Foresight Diagnostics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Foresight Diagnostics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Foresight Diagnostics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.